| Autor: |
Maurizio Salvadori, Alberto Rosati, Giuseppina Rosso |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Transplantology, Vol 5, Iss 3, Pp 224-233 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2673-3943 |
| DOI: |
10.3390/transplantology5030022 |
| Popis: |
Sodium glucose cotransporter type 2 inhibitors are a new class of drugs that act on the cardiovascular system, kidneys and metabolism in a multiple ways. Indeed, even though their principal action involves the transport of sodium and glucose in the convoluted distal tubule, they have multiple actions, such as antifibrotic and endothelial protective effects. Their principal mechanism consists of the loss of sodium and glucose. Therefore, they affect blood pressure and glucose metabolism. Their first use was in the diabetic general population; later, some studies documented their activity in the nondiabetic general population and in heart failure in chronic kidney disease patients. Only in recent years have several small studies documented the efficacy of these drugs in diabetic and nondiabetic kidney transplant patients; relatively large studies are rare, very recent, and open new routes for the development of these drugs. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
